Skip to content
healthcare.dev

METHSCOPOLAMINE BROMIDE

NDC 72319-029, methscopolamine bromide, tablet, from i3 Pharmaceuticals, LLC.

Product NDC
72319-029
Status
Listed
Labeler
i3 Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216786
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72319-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHSCOPOLAMINE BROMIDE2.5 mg/1

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]

Package NDCNDC-11Package
72319-029-0472319002904100 TABLET in 1 BOTTLE (72319-029-04)
72319-029-06723190029061000 TABLET in 1 BOTTLE (72319-029-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14c0c030-e96d-4a5e-95ff-02dd78a46be3
  • NADAC price for package 72319002904

    GET /v1/drugs/nadac/72319002904

Use it

Look up 72319-029 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72319-029 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72319-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.